Actinium Pharmaceuticals, Inc.

ATNMNew York Stock Exchange American·USD·Closed

ATNMNew York Stock Exchange American·USD·Closed

$1.10

−4.74%

$1.10

−$0.06 (4.74%)

52W Range

15thpctl

Volume

1.30×avg

Mkt Cap

34.67MUSD

P/E

-1.3TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

15thpctl

Volume

1.30×avg

Market Cap

34.67MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-28346.7%

ROIC-65.7%

Financially safe

Stretched

Debt / equity0.66×

Interest coverage0.0×

Current ratio5.89×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required